Patents by Inventor Otto Gaa

Otto Gaa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10716504
    Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: July 21, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Nicole Bernini, Harvey B. Buck, Jr., Andreas Eberhart, Sybille Froech, Otto Gaa, Michael Marquant, Juergen Rasch-Menges, Bernd Roesicke, Joerg Scherer
  • Patent number: 9869679
    Abstract: Methods are provided for photometrically determining/detecting sample application to an analytical test element for use with a blood glucose measuring device, where the method includes obtaining a sequence of reflectance readings from the test element with the measuring device, including a blank value prior to sample application, and then monitoring changes of the reflectance readings from the test element with respect to a sample application condition defined by a limit for a reflectance decrease or a reflectance threshold. The methods also can include adjusting the sample application condition in accordance with a drift correction and can include determining an analyte concentration in the body fluid sample. In addition, photometric blood glucose measuring devices are provided that incorporate the methods disclosed herein.
    Type: Grant
    Filed: March 5, 2015
    Date of Patent: January 16, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Gertrud Albrecht, Otto Gaa, Robert Lorenz, Frank Rueckert
  • Publication number: 20170357766
    Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.
    Type: Application
    Filed: August 28, 2017
    Publication date: December 14, 2017
    Inventors: Nicole BERNINI, Harvey B. BUCK, JR., Andreas EBERHART, Sybille FROECH, Otto GAA, Michael MARQUANT, Juergen RASCH-MENGES, Bernd ROESICKE, Joerg SCHERER
  • Patent number: 9773093
    Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: September 26, 2017
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Nicole Bernini, Harvey B. Buck, Jr., Andreas Eberhart, Sybille Froech, Otto Gaa, Michael Marquant, Juergen Rasch-Menges, Bernd Roesicke, Joerg Scherer
  • Publication number: 20170251922
    Abstract: The analyte concentration, such as glucose, in a human or animal body is measured with an implantable sensor that generates measurement signals. The measurement signals are compressed through statistical techniques to produced compressed measurement data that can is easier to process and communicate. A base station carries the implantable sensor along with a signal processor, memory, and a transmitter. A display device is also disclosed that can receive the compressed measurement data from the base station for further processing and display.
    Type: Application
    Filed: April 13, 2017
    Publication date: September 7, 2017
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Bernd Roesicke, Karin Obermaier, Stefan Lindegger, Andreas Menke, Joerg Scherer, Karin Schwind, Otto Gaa, Gregor Bainczyk, Michael Marquant, Sandro Niederhauser, Michael Schoemaker, Martin Mueri
  • Patent number: 9636049
    Abstract: The analyte concentration, such as glucose, in a human or animal body is measured with an implantable sensor that generates measurement signals. The measurement signals are compressed through statistical techniques to produced compressed measurement data that can is easier to process and communicate. A base station carries the implantable sensor along with a signal processor, memory, and a transmitter. A display device is also disclosed that can receive the compressed measurement data from the base station for further processing and display.
    Type: Grant
    Filed: November 11, 2013
    Date of Patent: May 2, 2017
    Assignee: ROCHE DIAGNOSTICS OPERATIONS, INC.
    Inventors: Bernd Roesicke, Karin Obermaier, Stefan Lindegger, Andreas Menke, Joerg Scherer, Karin Schwind, Otto Gaa, Gregor Bainczyk, Michael Marquant, Sandro Niederhauser, Michael Schoemaker, Martin Mueri
  • Publication number: 20160108391
    Abstract: Dry reagent compositions are disclosed that include one or more of an enzyme such as a dehydrogenase, a redox cofactor, an agent capable of eliciting at least one measurable change in a property of an indicator reagent in the presence of redox equivalents, an indicator reagent, and a pyridine-carboxylic acid, derivative or salt thereof. Also provided are diagnostic test elements including the reagent compositions for use in body fluid analysis. Further provided are methods of making test elements, as well as methods of body fluid analysis with such test elements. In the compositions, the pyridine-carboxylic acid, derivative or salt thereof attenuates, reduces or prevents a decrease of enzymatic activity of the at least one dehydrogenase under dry and/or humid conditions.
    Type: Application
    Filed: November 9, 2015
    Publication date: April 21, 2016
    Applicant: ROCHE DIABETES CARE, INC.
    Inventors: Gabriele Chemnitius, Thomas Nagel, Otto Gaa, Karl Recht
  • Publication number: 20150356264
    Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.
    Type: Application
    Filed: August 7, 2015
    Publication date: December 10, 2015
    Inventors: Nicole BERNINI, Harvey B. BUCK, JR., Andreas EBERHART, Sybille FROECH, Otto GAA, Michael MARQUANT, Juergen RASCH-MENGES, Bernd ROESICKE, Joerg SCHERER
  • Patent number: 9101306
    Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: August 11, 2015
    Assignees: Roche Diagnostics Operations, Inc., Roche Diagnostics International AG
    Inventors: Nicole Bernini, Harvey B. Buck, Jr., Andreas Eberhart, Sybille Froech, Otto Gaa, Michael Marquant, Juergen Rasch-Menges, Bernd Roesicke, Joerg Scherer
  • Publication number: 20150177257
    Abstract: Methods are provided for photometrically determining/detecting sample application to an analytical test element for use with a blood glucose measuring device, where the method includes obtaining a sequence of reflectance readings from the test element with the measuring device, including a blank value prior to sample application, and then monitoring changes of the reflectance readings from the test element with respect to a sample application condition defined by a limit for a reflectance decrease or a reflectance threshold. The methods also can include adjusting the sample application condition in accordance with a drift correction and can include determining an analyte concentration in the body fluid sample. In addition, photometric blood glucose measuring devices are provided that incorporate the methods disclosed herein.
    Type: Application
    Filed: March 5, 2015
    Publication date: June 25, 2015
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Gertrud Albrecht, Otto Gaa, Robert Lorenz, Frank Rueckert
  • Publication number: 20140363835
    Abstract: Dry reagent compositions are disclosed for maintaining and preserving enzymatic activity. Also disclosed are test elements incorporating the same and methods of making and using the same for determining the presence or amount of an analyte in a body fluid sample. The dry reagent compositions can include components such as a dehydrogenase, a redox cofactor, an agent capable of eliciting at least one optical change in an optical property of an indicator reagent in the presence of redox equivalents, an indicator reagent, and at least one compatible solute being ectoine or a derivative thereof.
    Type: Application
    Filed: August 22, 2014
    Publication date: December 11, 2014
    Inventors: Gabriele Chemnitius, Otto Gaa, Thomas Nagel, Karl Recht
  • Patent number: 8721544
    Abstract: The analyte concentration, such as glucose, in a human or animal body is measured with an implantable sensor that generates measurement signals. The measurement signals are compressed through statistical techniques to produced compressed measurement data that can is easier to process and communicate. A base station carries the implantable sensor along with a signal processor, memory, and a transmitter. A display device is also disclosed that can receive the compressed measurement data from the base station for further processing and display.
    Type: Grant
    Filed: March 20, 2008
    Date of Patent: May 13, 2014
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Bernd Roesicke, Karin Obermaier, Stefan Lindegger, Andreas Menke, Joerg Scherer, Karin Schwind, Otto Gaa, Gregor Bainczyk, Michael Marquant, Sandro Niederhäuser, Michael Schoemaker, Martin Mueri
  • Publication number: 20140066730
    Abstract: The analyte concentration, such as glucose, in a human or animal body is measured with an implantable sensor that generates measurement signals. The measurement signals are compressed through statistical techniques to produced compressed measurement data that can is easier to process and communicate. A base station carries the implantable sensor along with a signal processor, memory, and a transmitter. A display device is also disclosed that can receive the compressed measurement data from the base station for further processing and display.
    Type: Application
    Filed: November 11, 2013
    Publication date: March 6, 2014
    Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.
    Inventors: Bernd Roesicke, Karin Obermaier, Stefan Lindegger, Andreas Menke, Joerg Scherer, Karin Schwind, Otto Gaa, Gregor Bainczyk, Michael Marquant, Sandro Niederhauser, Michael Schoemaker, Martin Mueri
  • Publication number: 20120245438
    Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.
    Type: Application
    Filed: September 22, 2011
    Publication date: September 27, 2012
    Inventors: Nicole Bernini, Harvey B. Buck, JR., Andreas Eberhart, Sybille Froech, Otto Gaa, Michael Marquant, Juergen Rasch-Menges, Bernd Roesicke, Joerg Scherer
  • Patent number: 7736904
    Abstract: The present invention pertains to a method for verifying usability of a test element on the basis of the relation of at least one control parameter measurable from the blank test field of a test element to a standard value for the at least one control parameter. In one embodiment, the method comprises determining the deviation between a first ratio calculated from a blank-field reference value measured for the control parameter and a first standard value, and a second ratio calculated from a blank-field control value and the first standard value, and rejecting a test element if the deviation is not within a predetermined tolerance range for the deviation.
    Type: Grant
    Filed: January 25, 2008
    Date of Patent: June 15, 2010
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Otto Gaa, Gertrud Albrecht, Dieter Loch-Leroux
  • Publication number: 20100144042
    Abstract: The invention concerns a method for automatically differentiating between a sample liquid and a control liquid especially within the context of analytical measuring systems, wherein the presence of a special property of the control liquid and/or at least two criteria are used for the differentiation. In addition the invention concerns appropriate control liquids that are suitable for the new method.
    Type: Application
    Filed: February 15, 2010
    Publication date: June 10, 2010
    Inventors: Guenter Frey, Carina Horn, Otto Gaa, Hans Kintzig, Hans-Ruediger Murawski
  • Patent number: 7670846
    Abstract: The invention concerns a method for automatically differentiating between a sample liquid and a control liquid especially within the context of analytical measuring systems, wherein the presence of a special property of the control liquid and/or at least two criteria are used for the differentiation. In addition the invention concerns appropriate control liquids that are suitable for the new method.
    Type: Grant
    Filed: June 24, 2003
    Date of Patent: March 2, 2010
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Guenter Frey, Carina Horn, Otto Gaa, Hans Kintzig, Hans-Ruediger Murawski
  • Publication number: 20080242962
    Abstract: The analyte concentration, such as glucose, in a human or animal body is measured with an implantable sensor that generates measurement signals. The measurement signals are compressed through statistical techniques to produced compressed measurement data that can is easier to process and communicate. A base station carries the implantable sensor along with a signal processor, memory, and a transmitter. A display device is also disclosed that can receive the compressed measurement data from the base station for further processing and display.
    Type: Application
    Filed: March 20, 2008
    Publication date: October 2, 2008
    Inventors: Bernd Roesicke, Karin Obermaier, Stefan Lindegger, Andreas Menke, Joerg Scherer, Karin Schwind, Otto Gaa, Gregor Bainczyk, Michael Marquant, Sandro Niederhauser, Michael Schoemaker, Martin Mueri
  • Publication number: 20080138906
    Abstract: The present invention pertains to a method for verifying usability of a test element on the basis of the relation of at least one control parameter measurable from the blank test field of a test element to a standard value for the at least one control parameter. In one embodiment, the method comprises determining the deviation between a first ratio calculated from a blank-field reference value measured for the control parameter and a first standard value, and a second ratio calculated from a blank-field control value and the first standard value, and rejecting a test element if the deviation is not within a predetermined tolerance range for the deviation.
    Type: Application
    Filed: January 25, 2008
    Publication date: June 12, 2008
    Inventors: Otto Gaa, Gertrud Albrecht, Dieter Loch-Leroux
  • Publication number: 20050244981
    Abstract: The invention concerns a method for automatically differentiating between a sample liquid and a control liquid especially within the context of analytical measuring systems, wherein the presence of a special property of the control liquid and/or at least two criteria are used for the differentiation. In addition the invention concerns appropriate control liquids that are suitable for the new method.
    Type: Application
    Filed: June 24, 2003
    Publication date: November 3, 2005
    Inventors: Guenter Frey, Carina Horn, Otto Gaa, Hans Kintzig, Hans-Ruediger Murawski